AU2001240018A1 - Adeno-associated viral compositions and methods - Google Patents

Adeno-associated viral compositions and methods

Info

Publication number
AU2001240018A1
AU2001240018A1 AU2001240018A AU4001801A AU2001240018A1 AU 2001240018 A1 AU2001240018 A1 AU 2001240018A1 AU 2001240018 A AU2001240018 A AU 2001240018A AU 4001801 A AU4001801 A AU 4001801A AU 2001240018 A1 AU2001240018 A1 AU 2001240018A1
Authority
AU
Australia
Prior art keywords
adeno
methods
associated viral
viral compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240018A
Inventor
Mark A Kay
Hiroyuki Nakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of AU2001240018A1 publication Critical patent/AU2001240018A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
AU2001240018A 2000-03-03 2001-03-01 Adeno-associated viral compositions and methods Abandoned AU2001240018A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18684300P 2000-03-03 2000-03-03
US60186843 2000-03-03
PCT/US2001/006808 WO2001066782A1 (en) 2000-03-03 2001-03-01 Adeno-associated viral compositions and methods

Publications (1)

Publication Number Publication Date
AU2001240018A1 true AU2001240018A1 (en) 2001-09-17

Family

ID=22686481

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240018A Abandoned AU2001240018A1 (en) 2000-03-03 2001-03-01 Adeno-associated viral compositions and methods

Country Status (3)

Country Link
US (1) US7060497B2 (en)
AU (1) AU2001240018A1 (en)
WO (1) WO2001066782A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436392B1 (en) 1998-05-20 2002-08-20 University Of Iowa Research Foundation Adeno-associated virus vectors
AU782966B2 (en) * 1999-06-08 2005-09-15 University Of Iowa Research Foundation, The Compounds and methods to enhance RAAV transduction
US7241447B1 (en) * 1999-10-07 2007-07-10 University Of Iowa Research Foundation Adeno-associated virus vectors and uses thereof
US20070202587A1 (en) * 2002-09-23 2007-08-30 Applied Genetic Technologies Corporation Recombinant AAV production in mammalian cells
US7091029B2 (en) * 2002-09-23 2006-08-15 Applied Genetics Technologies Corporation High titer recombinant AAV production
CA2520028A1 (en) * 2003-03-31 2004-10-21 University Of Iowa Research Foundation Compounds and methods to enhance raav transduction
EP2007795B1 (en) 2006-03-30 2016-11-16 The Board Of Trustees Of The Leland Stanford Junior University Aav capsid proteins
US11702672B2 (en) 2016-02-08 2023-07-18 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
CA3198936A1 (en) 2016-03-07 2017-09-14 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
CN110225975A (en) 2016-08-23 2019-09-10 阿库斯股份有限公司 For treating the composition and method of non-age-dependent hearing impairment in people experimenter
WO2020092904A1 (en) * 2018-11-02 2020-05-07 Nikegen, Llc Recombinant parvoviral vectors and method of making and use thereof
BR112022016596A2 (en) 2020-02-21 2022-11-16 Akouos Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN INDIVIDUAL

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587308A (en) * 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US6924128B2 (en) * 1994-12-06 2005-08-02 Targeted Genetics Corporation Packaging cell lines for generation of high titers of recombinant AAV vectors
US5843742A (en) 1994-12-16 1998-12-01 Avigen Incorporated Adeno-associated derived vector systems for gene delivery and integration into target cells
US5952221A (en) 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
US5830730A (en) * 1997-05-08 1998-11-03 The Regents Of The University Of California Enhanced adenovirus-assisted transfection composition and method
US6436392B1 (en) * 1998-05-20 2002-08-20 University Of Iowa Research Foundation Adeno-associated virus vectors

Also Published As

Publication number Publication date
US20020058341A1 (en) 2002-05-16
US7060497B2 (en) 2006-06-13
WO2001066782A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2778801A (en) Antisense compositions and methods
AU2002357119A1 (en) Mitocidal compositions and methods
AUPQ419099A0 (en) Novel compositions and methods
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AUPQ875700A0 (en) Combination compositions
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001240018A1 (en) Adeno-associated viral compositions and methods
AU2001241098A1 (en) Composition
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1152601A (en) Compositions and their use
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001275201A1 (en) Acne-treating composition
AU2001287852A1 (en) Composition
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2001235764A1 (en) Compositions
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001232080A1 (en) Compound, compositions and use
AU2001239954A1 (en) Cleaning compositions and use thereof
AU2001262163A1 (en) Composition